EP0345883A3 - Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin - Google Patents

Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin Download PDF

Info

Publication number
EP0345883A3
EP0345883A3 EP19890201411 EP89201411A EP0345883A3 EP 0345883 A3 EP0345883 A3 EP 0345883A3 EP 19890201411 EP19890201411 EP 19890201411 EP 89201411 A EP89201411 A EP 89201411A EP 0345883 A3 EP0345883 A3 EP 0345883A3
Authority
EP
European Patent Office
Prior art keywords
dapiprazole
pharmaceutical composition
morphine
tolerance
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP19890201411
Other languages
English (en)
French (fr)
Other versions
EP0345883A2 (de
EP0345883B1 (de
Inventor
Bruno Silvestrini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority to AT89201411T priority Critical patent/ATE96025T1/de
Publication of EP0345883A2 publication Critical patent/EP0345883A2/de
Publication of EP0345883A3 publication Critical patent/EP0345883A3/de
Application granted granted Critical
Publication of EP0345883B1 publication Critical patent/EP0345883B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EP89201411A 1988-06-10 1989-06-02 Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin Expired - Lifetime EP0345883B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT89201411T ATE96025T1 (de) 1988-06-10 1989-06-02 Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4807188 1988-06-10
IT48071/88A IT1224250B (it) 1988-06-10 1988-06-10 Associzione del depiprazolo con la morfina

Publications (3)

Publication Number Publication Date
EP0345883A2 EP0345883A2 (de) 1989-12-13
EP0345883A3 true EP0345883A3 (de) 1991-09-25
EP0345883B1 EP0345883B1 (de) 1993-10-20

Family

ID=11264351

Family Applications (1)

Application Number Title Priority Date Filing Date
EP89201411A Expired - Lifetime EP0345883B1 (de) 1988-06-10 1989-06-02 Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin

Country Status (7)

Country Link
US (1) US5041446A (de)
EP (1) EP0345883B1 (de)
JP (1) JPH0232020A (de)
AT (1) ATE96025T1 (de)
DE (2) DE68910010D1 (de)
GR (1) GR900300082T1 (de)
IT (1) IT1224250B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250701B (it) * 1991-07-24 1995-04-21 Angelini Francesco Ist Ricerca Composizione farmaceutica solida per uso orale a base di dapiprazolo
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US6730691B1 (en) 2000-02-10 2004-05-04 Miles A. Galin Uses of alpha adrenergic blocking agents
EP1476155A4 (de) * 2002-01-23 2009-10-28 Univ California Verfahren und zusammensetzungen zur verringerung der entstehung von arzneimitteltoleranz und/oder physischer abhängigkeit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252721A (en) * 1978-04-18 1981-02-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Cycloalkyltriazoles and process for obtaining same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252721A (en) * 1978-04-18 1981-02-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Cycloalkyltriazoles and process for obtaining same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ARZNEIMITTELFORSCHUNG, vol. 32, no. 6, 1983, pages 668-673; B. SILVESTRINI et al.: "Psychopharmacological profile of dapiprazole, a new potential antipsychotic agent" *
DRUG AND ALCOHOL DEPENDENCE, vol. 23, no. 1, January 1989, pages 73-77, Elsevier Scientific Publishers Ireland, Ltd, IR; P. VALERI et al.: "Effects of dapiprazole, clonidine and yohimbine on the development of dependence and withdrawal behaviour in mice" *
DRUGS EXPTL. CLIN. RES., vol. 14, no. 1, 1988, pages 53-58, Bioscience Ediprint Inc.; P. VALERI et al.: "Binding profile of trazodone and dapiprazole to some brain receptors" *
GIORN. CHIR., vol. 9, no. 1, January 1988, pages 43-46; S. CAMPAGNA et al.: "Uso del trazodone nel dolore postoperatorio" *

Also Published As

Publication number Publication date
IT1224250B (it) 1990-09-26
JPH0232020A (ja) 1990-02-01
IT8848071A0 (it) 1988-06-10
EP0345883A2 (de) 1989-12-13
US5041446A (en) 1991-08-20
DE68910010D1 (de) 1993-11-25
GR900300082T1 (en) 1991-07-31
DE345883T1 (de) 1990-05-03
ATE96025T1 (de) 1993-11-15
EP0345883B1 (de) 1993-10-20

Similar Documents

Publication Publication Date Title
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
GR890100636A (en) Analgesic compositions
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
CA2202531A1 (en) Lyophilizate of lipid complex of water insoluble camptothecins
EP1167354A3 (de) Racemisches Huperzin A
ZA869586B (en) Pharmaceutical product for the sustained release of ibuprofen
EP0406347A4 (en) Anti-inflammatory and analgesic compounds, related compositions and methods for preparation and use thereof
HK80492A (en) Pharmaceutical compositions with analgesic properties and the preparation and use thereof
EP0367533A3 (de) Methode zur Behandlung des interstitiellen Blasenentzündung
EP0345883A3 (de) Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin
GR900300044T1 (en) Use of monosubstitute selenium compounds in the preparation of a pharmaceutical, pharmaceutical and preparation thereof
EP0362847A3 (de) Verwendung von Etoperidon zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von männlicher Impotenz
HUT50765A (en) Process for producing compounds with analgesic action on central nervous system and pharmaceutical compositions comprising such compounds
AU574978B2 (en) Method for treatment of antidiuresis employing serine derivatives
AU2908389A (en) Device for administering medicaments by atomization in intubated or tracheotomized patients
CA2090234A1 (en) Method for providing improved analgesic effect
EP0353631A3 (de) Isoxazolobenzoxazepine, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU2469088A (en) Pharmaceutical composition for the parenteral administration of navelbine
RU93016321A (ru) Средство для купирования абстинентного синдрома при опийных наркоманиях
AU1778088A (en) Use of analgesic anti-inflammatory drugs in treating haemorrhoidal bleeding
AU681592B2 (en) A percutaneous salve preparation in the form of a patch
RU93042104A (ru) Противокашлевая композиция, содержащая декстрометорфан, способ ее применения
EP0174980A4 (de) Verwendung von einer Mangan Komponente zur Herstellung eines Medikaments für die Behandlung von Hypothyroidism.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

TCAT At: translation of patent claims filed
TCNL Nl: translation of patent claims filed
ITCL It: translation for ep claims filed

Representative=s name: MARCHI E MITTLER

EL Fr: translation of claims filed
DET De: translation of patent claims
PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

17P Request for examination filed

Effective date: 19920203

17Q First examination report despatched

Effective date: 19920622

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRE;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.SCRIBED TIME-LIMIT

Effective date: 19931020

Ref country code: BE

Effective date: 19931020

Ref country code: FR

Effective date: 19931020

Ref country code: DE

Effective date: 19931020

Ref country code: SE

Effective date: 19931020

Ref country code: AT

Effective date: 19931020

Ref country code: NL

Effective date: 19931020

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19931020

REF Corresponds to:

Ref document number: 96025

Country of ref document: AT

Date of ref document: 19931115

Kind code of ref document: T

REF Corresponds to:

Ref document number: 68910010

Country of ref document: DE

Date of ref document: 19931125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19940131

EN Fr: translation not filed
NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19940602

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19940630

Ref country code: CH

Effective date: 19940630

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19940630

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19940602

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL